Listeners will join Deshaies on the journey of the development of the next revolution of drug discovery to treat diseases considered undruggable. In the second podcast launching in October, Ray Deshaies will chat with Amgen colleagues and outside experts in a 5-episode serial called Undruggable. This is available to all from The Scientist website.ĭNA Unlocked is the first of two serial podcasts in partnership with The Scientist. There’s more! The Scientist will host free online, live Q&A webinars during three Wednesdays of the episode run featuring Amgen scientists. September 16: Episode 5 - Reshaping the Future with Amit Khera, M.D., MGH Center for Genomic Medicine.September 9: Episode 4 - Unlocking the Genetics of Cancer with Angela Coxon, vice president of Oncology Research at Amgen.September 2: Episode 3 - Beyond Genomics with Larry Gold, Ph.D., founder of Somalogic.Biology with Saptarsi Haldar, M.D., vice president of Cardiometabolic Research at Amgen August 19: Episode 1 - Promise and the Potential with Richard Scheller, Ph.D., former chief scientific officer of 23andMe and former executive vice president of Research and Early Development at Genentech.Listen in every week or binge! Here are the dates and details so you can catch all the action: You can find DNA Unlocked on The Scientist podcast platform, Apple Podcasts, Spotify, Stitcher, iHeartRadio, Google Podcasts, and many more. The first episode launches on Thursday, August 19 and continues with a new episode every Thursday through September 16. Deshaies is joined by pioneers and leaders in genomics including Richard Scheller, Ph.D., former Chief Scientific Officer of 23 and Me and former executive vice president of Genentech Saptarsi Haldar, M.D., vice president of Cardiometabolic Research at Amgen Larry Gold, Ph.D, founder of Somalogic Angela Coxon, Ph.D., vice president of Oncology Research at Amgen and Amit Khera, M.D., Massachusetts General Hospital (MGH) Center for Genomic Medicine. Over five episodes, DNA Unlocked covers topics ranging from the promise and potential of decoding DNA to the genetics of cancer and how understanding human biology is reshaping the future of precision medicine. Ray Deshaies, senior vice president, Global Research Founded in 1996, deCODE genetics is a global leader in analyzing and understanding the. Clinical Trial Diversity and RepresentationĬlinical Trial Transparency, Data Sharing and Disclosure PracticesĪdverse Event and Product Complaint ReportingĮnvironmental, Social & Governance Report 2022Įnvironment, Social and Governance StrategyĬommunity Investment and Amgen Foundation NextCODE Health was spun out from deCODE genetics after the latter was acquired by Amgen in December 2012.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |